Spots Global Cancer Trial Database for unspecified childhood solid tumor, protocol specific
Every month we try and update this database with for unspecified childhood solid tumor, protocol specific cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Dactinomycin in Young Patients With Cancer | NCT00900354 | Unspecified Chi... | molecular genet... mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Oxaliplatin in Treating Children With Advanced Solid Tumors | NCT00005844 | Unspecified Chi... | oxaliplatin | - 21 Years | St. Jude Children's Research Hospital | |
| FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia | NCT00053963 | Blastic Phase C... Childhood Centr... Childhood Choro... Childhood Chron... Childhood Crani... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Spina... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Refractory Chro... Relapsing Chron... Unspecified Chi... | romidepsin | - 21 Years | National Cancer Institute (NCI) | |
| Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | NCT01346267 | Central Nervous... Chemotherapy-in... Unspecified Chi... | Real Acupressur... Placebo Acupres... | 4 Years - 18 Years | University of South Florida | |
| Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant | NCT00003894 | Graft Versus Ho... Unspecified Adu... Unspecified Chi... | thalidomide | 3 Years - | Roswell Park Cancer Institute | |
| High-Dose Methotrexate in Treating Young Patients With Solid Tumors | NCT00513981 | Brain and Centr... Sarcoma Unspecified Chi... | leucovorin calc... methotrexate mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors | NCT01141244 | Unspecified Chi... | temsirolimus temozolomide irinotecan hydr... laboratory biom... | 2 Years - 21 Years | National Cancer Institute (NCI) | |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | NCT00006102 | Brain and Centr... Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Chi... | becatecarin | - 21 Years | National Cancer Institute (NCI) | |
| Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors | NCT00039481 | Cardiac Toxicit... Unspecified Chi... | oblimersen sodi... dexrazoxane hyd... doxorubicin hyd... cyclophosphamid... filgrastim laboratory biom... pharmacological... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy | NCT00006095 | Unspecified Chi... | irinotecan hydr... vincristine sul... | 1 Year - 21 Years | Children's Oncology Group | |
| BMS-214662 in Treating Patients With Solid Tumors | NCT00005973 | Unspecified Adu... Unspecified Chi... | BMS-214662 laboratory biom... | - | National Cancer Institute (NCI) | |
| Bevacizumab in Treating Young Patients With Refractory Solid Tumors | NCT00085111 | Unspecified Chi... | bevacizumab | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
| Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment | NCT00929903 | Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Metastatic Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi... | pazopanib hydro... pharmacological... | 2 Years - 25 Years | National Cancer Institute (NCI) | |
| Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer | NCT00357500 | Central Nervous... Leukemia Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | celecoxib cyclophosphamid... etoposide fenofibrate thalidomide | - 21 Years | Dana-Farber Cancer Institute | |
| High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors | NCT00003173 | Brain and Centr... Childhood Germ ... Extragonadal Ge... Ovarian Cancer Retinoblastoma Testicular Germ... Unspecified Adu... Unspecified Chi... | filgrastim thiotepa autologous bone... peripheral bloo... | - | Memorial Sloan Kettering Cancer Center | |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
| Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy | NCT00004919 | Unspecified Chi... | cisplatin irinotecan hydr... amifostine trih... pharmacological... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | NCT01346267 | Central Nervous... Chemotherapy-in... Unspecified Chi... | Real Acupressur... Placebo Acupres... | 4 Years - 18 Years | University of South Florida | |
| AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors | NCT00985868 | Unspecified Chi... | multikinase inh... enzyme-linked i... immunohistochem... laboratory biom... pharmacological... | 2 Years - 18 Years | Cancer Research UK | |
| Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy | NCT00006095 | Unspecified Chi... | irinotecan hydr... vincristine sul... | 1 Year - 21 Years | Children's Oncology Group | |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
| Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants | NCT00459238 | Unspecified Chi... | counseling inte... educational int... | 13 Years - 21 Years | Georgetown University | |
| Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation | NCT00003898 | Oral Complicati... Unspecified Chi... | glutamine | 1 Year - 21 Years | Roswell Park Cancer Institute | |
| Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors | NCT00900471 | Unspecified Adu... Unspecified Chi... | biologic sample... medical chart r... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors | NCT01240538 | Unspecified Chi... | wild-type reovi... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | National Cancer Institute (NCI) | |
| Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors | NCT00070473 | Unspecified Chi... | pemetrexed diso... | 1 Year - 21 Years | Children's Oncology Group | |
| Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers | NCT00003754 | Unspecified Chi... | cyclophosphamid... thalidomide | - | Memorial Sloan Kettering Cancer Center | |
| Tissue Sample Collection From Patients With Fanconi Anemia | NCT00899522 | Fanconi Anemia Unspecified Adu... Unspecified Chi... | biologic sample... biopsy | 1 Year - 55 Years | OHSU Knight Cancer Institute | |
| Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors | NCT00436761 | Unspecified Chi... | anti-thymocyte ... graft-versus-tu... sargramostim busulfan cyclosporine melphalan methylprednisol... flow cytometry immunologic tec... laboratory biom... allogeneic hema... umbilical cord ... | - 21 Years | National Cancer Institute (NCI) | |
| Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | NCT01346267 | Central Nervous... Chemotherapy-in... Unspecified Chi... | Real Acupressur... Placebo Acupres... | 4 Years - 18 Years | University of South Florida | |
| Gemcitabine in Treating Children With Refractory Solid Tumors | NCT00005577 | Unspecified Chi... | gemcitabine hyd... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Pharmacokinetics of Daunorubicin in Young Patients With Cancer | NCT00673257 | Unspecified Chi... | pharmacological... dual x-ray abso... | - 21 Years | Children's Oncology Group | |
| Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression | NCT00069927 | Depression Neurotoxicity Unspecified Chi... | Adderall-XR® Concerta® | 6 Years - 17 Years | University of South Florida | |
| Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | NCT01791088 | Unspecified Adu... Unspecified Chi... | sirolimus pharmacological... laboratory biom... | 12 Years - | University of Chicago | |
| Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment | NCT00880282 | Unspecified Chi... | cixutumumab temsirolimus pharmacological... laboratory biom... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia | NCT00079404 | Acute Undiffere... Recurrent Child... Recurrent Child... Secondary Acute... Unspecified Chi... | tanespimycin | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Irofulven in Treating Children With Recurrent or Refractory Solid Tumors | NCT00003370 | Unspecified Chi... | irofulven | - 21 Years | National Cancer Institute (NCI) | |
| Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer | NCT00898794 | Unspecified Adu... Unspecified Chi... | bevacizumab coagulation stu... laboratory biom... platelet aggreg... | - | National Cancer Institute (NCI) | |
| Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants | NCT00459238 | Unspecified Chi... | counseling inte... educational int... | 13 Years - 21 Years | Georgetown University | |
| Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors | NCT01240538 | Unspecified Chi... | wild-type reovi... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | National Cancer Institute (NCI) | |
| Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer | NCT00607802 | Unspecified Adu... Unspecified Chi... | leukocyte thera... polymerase chai... | - 120 Years | Wake Forest University Health Sciences | |
| Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy | NCT00296049 | Infection Neutropenia Unspecified Adu... Unspecified Chi... | daptomycin vancomycin | - 120 Years | Wake Forest University Health Sciences | |
| Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | NCT00002543 | Brain and Centr... Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | gallium nitrate | - 21 Years | National Cancer Institute (NCI) | |
| Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin | NCT00458887 | Ototoxicity Unspecified Chi... | management of t... | 1 Year - 18 Years | Children's Oncology Group | |
| Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate | NCT00018967 | Neurotoxicity Unspecified Adu... Unspecified Chi... | glucarpidase | - | National Cancer Institute (NCI) | |
| Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer | NCT00003070 | Cardiac Toxicit... Unspecified Chi... | enalapril malea... quality-of-life... | 8 Years - | Children's Oncology Group | |
| Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors | NCT00003288 | Unspecified Chi... | filgrastim cyclophosphamid... tirapazamine | - 21 Years | National Cancer Institute (NCI) | |
| Irofulven in Treating Children With Recurrent or Refractory Solid Tumors | NCT00003370 | Unspecified Chi... | irofulven | - 21 Years | National Cancer Institute (NCI) | |
| Sunitinib in Treating Young Patients With Refractory Solid Tumors | NCT00387920 | Central Nervous... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Recurrent Child... Unspecified Chi... | sunitinib malat... pharmacological... dynamic contras... laboratory biom... | 2 Years - 21 Years | National Cancer Institute (NCI) | |
| Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma | NCT00075634 | Recurrent Neuro... Unspecified Chi... | decitabine doxorubicin hyd... cyclophosphamid... filgrastim pegfilgrastim laboratory biom... pharmacological... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma | NCT00363272 | Childhood Burki... Childhood Centr... Childhood Choro... Childhood Crani... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Spina... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi... | ispinesib laboratory biom... pharmacological... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors | NCT00003194 | Unspecified Chi... | filgrastim carboplatin cyclophosphamid... etoposide thiotepa topotecan hydro... peripheral bloo... | 1 Year - 30 Years | Seattle Children's Hospital | |
| Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | NCT00004005 | Carcinoma of Un... Colorectal Canc... Unspecified Adu... Unspecified Chi... | fluorouracil irinotecan hydr... leucovorin calc... conventional su... radiation thera... | - 24 Years | St. Jude Children's Research Hospital | |
| Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes | NCT00104962 | Childhood Myelo... de Novo Myelody... Previously Trea... Refractory Anem... Refractory Anem... Refractory Anem... Refractory Cyto... Secondary Myelo... Unspecified Chi... | lenalidomide | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| BMS-214662 in Treating Patients With Solid Tumors | NCT00005973 | Unspecified Adu... Unspecified Chi... | BMS-214662 laboratory biom... | - | National Cancer Institute (NCI) | |
| Ecteinascidin 743 in Treating Children With Refractory Solid Tumors | NCT00006463 | Unspecified Chi... | ECTEINASCIDIN 7... | 1 Year - 17 Years | Children's Oncology Group | |
| Positron Emission Tomography/Magnetic Resonance Imaging in Patients | NCT01557881 | Colon Cancer Head and Neck C... Lung Cancer Lymphoma Malignant Neopl... Melanoma Unspecified Adu... Unspecified Chi... | magnetic resona... | - | Case Comprehensive Cancer Center | |
| Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy | NCT00258180 | Diarrhea Gastrointestina... Unspecified Chi... | filgrastim cyclophosphamid... | 1 Year - 21 Years | Johns Hopkins University | |
| High-Dose Methotrexate in Treating Young Patients With Solid Tumors | NCT00513981 | Brain and Centr... Sarcoma Unspecified Chi... | leucovorin calc... methotrexate mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Oxaliplatin in Treating Children With Advanced Solid Tumors | NCT00005844 | Unspecified Chi... | oxaliplatin | - 21 Years | St. Jude Children's Research Hospital | |
| Dextromethorphan in Treating Patients With Fatigue Caused by Cancer | NCT00176540 | Fatigue Unspecified Adu... Unspecified Chi... | dextromethorpha... | 12 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate | NCT00018967 | Neurotoxicity Unspecified Adu... Unspecified Chi... | glucarpidase | - | National Cancer Institute (NCI) | |
| Fenretinide in Treating Children With Solid Tumors | NCT00003191 | Neuroblastoma Unspecified Chi... | fenretinide | - 21 Years | National Cancer Institute (NCI) | |
| Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants | NCT00459238 | Unspecified Chi... | counseling inte... educational int... | 13 Years - 21 Years | Georgetown University | |
| Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer | NCT00897871 | Unspecified Chi... | carboplatin cyclophosphamid... etoposide phosp... gene expression... polymorphism an... pharmacological... | - 2 Years | National Cancer Institute (NCI) | |
| Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center | NCT00670605 | Unspecified Adu... Unspecified Chi... | medical chart r... study of socioe... | 15 Years - 30 Years | Vanderbilt University | |
| Pharmacokinetics of Dactinomycin in Young Patients With Cancer | NCT00900354 | Unspecified Chi... | molecular genet... mass spectromet... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy | NCT00429702 | Nausea Vomiting Unspecified Chi... | Decadron® Benadryl® Ativan® ondansetron hyd... | 8 Years - 18 Years | University of South Florida | |
| Registration and Informed Consent Study for the Childhood Cancer Research Network | NCT00433394 | Unspecified Chi... | cancer preventi... educational int... | - 20 Years | Children's Oncology Group | |
| Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes | NCT00104962 | Childhood Myelo... de Novo Myelody... Previously Trea... Refractory Anem... Refractory Anem... Refractory Anem... Refractory Cyto... Secondary Myelo... Unspecified Chi... | lenalidomide | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Ecteinascidin 743 in Treating Children With Refractory Solid Tumors | NCT00006463 | Unspecified Chi... | ECTEINASCIDIN 7... | 1 Year - 17 Years | Children's Oncology Group | |
| Gemcitabine in Treating Children With Refractory Solid Tumors | NCT00005577 | Unspecified Chi... | gemcitabine hyd... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer | NCT00003070 | Cardiac Toxicit... Unspecified Chi... | enalapril malea... quality-of-life... | 8 Years - | Children's Oncology Group | |
| Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors | NCT01141244 | Unspecified Chi... | temsirolimus temozolomide irinotecan hydr... laboratory biom... | 2 Years - 21 Years | National Cancer Institute (NCI) | |
| Irinotecan in Treating Children With Refractory or Progressive Solid Tumors | NCT00016861 | Unspecified Chi... | irinotecan hydr... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center | NCT00670605 | Unspecified Adu... Unspecified Chi... | medical chart r... study of socioe... | 15 Years - 30 Years | Vanderbilt University | |
| Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | NCT00002543 | Brain and Centr... Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | gallium nitrate | - 21 Years | National Cancer Institute (NCI) | |
| Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment | NCT00929903 | Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Metastatic Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi... | pazopanib hydro... pharmacological... | 2 Years - 25 Years | National Cancer Institute (NCI) | |
| FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia | NCT00053963 | Blastic Phase C... Childhood Centr... Childhood Choro... Childhood Chron... Childhood Crani... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Spina... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Refractory Chro... Relapsing Chron... Unspecified Chi... | romidepsin | - 21 Years | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
